BR112013003031A2 - método de produção de células hastes neurais (chn), células hastes neurais e seu uso, composição terapêutica e banco biológico de nscs - Google Patents
método de produção de células hastes neurais (chn), células hastes neurais e seu uso, composição terapêutica e banco biológico de nscsInfo
- Publication number
- BR112013003031A2 BR112013003031A2 BR112013003031A BR112013003031A BR112013003031A2 BR 112013003031 A2 BR112013003031 A2 BR 112013003031A2 BR 112013003031 A BR112013003031 A BR 112013003031A BR 112013003031 A BR112013003031 A BR 112013003031A BR 112013003031 A2 BR112013003031 A2 BR 112013003031A2
- Authority
- BR
- Brazil
- Prior art keywords
- stem cells
- neural stem
- chn
- therapeutic composition
- nscs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/405—Cell cycle regulated proteins, e.g. cyclins, cyclin-dependant kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
método de produção de células hastes neurais (chn), células hastes neurais e seu uso, composição terapêutica e banco biológico de nsns. o presente pedido refere-se a um método de conversão de células somáticas em células hastes neurais (nscs). além disso, o presente pedido refere-se a um método de conversão de fibroblastas humanos, queratinócitos ou adipócitos em células hastes neurais com base em etapas ligadas de transdução genética e indução de meio quimicamente definido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10173455 | 2010-08-19 | ||
PCT/EP2011/064051 WO2012022725A2 (en) | 2010-08-19 | 2011-08-16 | Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013003031A2 true BR112013003031A2 (pt) | 2016-06-14 |
Family
ID=43734036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013003031A BR112013003031A2 (pt) | 2010-08-19 | 2011-08-16 | método de produção de células hastes neurais (chn), células hastes neurais e seu uso, composição terapêutica e banco biológico de nscs |
Country Status (12)
Country | Link |
---|---|
US (2) | US9297025B2 (pt) |
EP (1) | EP2606126B1 (pt) |
JP (1) | JP5905006B2 (pt) |
KR (2) | KR101788903B1 (pt) |
CN (1) | CN103068974B (pt) |
BR (1) | BR112013003031A2 (pt) |
CA (1) | CA2807226A1 (pt) |
ES (1) | ES2580837T3 (pt) |
HK (1) | HK1184492A1 (pt) |
MX (1) | MX348419B (pt) |
RU (1) | RU2562111C2 (pt) |
WO (1) | WO2012022725A2 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012022725A2 (en) | 2010-08-19 | 2012-02-23 | F. Hoffmann-La Roche Ag | Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs) |
CN102604894B (zh) * | 2012-02-29 | 2014-07-30 | 中国科学院广州生物医药与健康研究院 | 用于制备神经干细胞的培养基及其用途 |
PL223189B1 (pl) * | 2012-11-15 | 2016-10-31 | Celther Polska Spółka Z Ograniczoną Odpowiedzialnością | Komórka iNS oraz sposób reprogramowania komórek somatycznych za pomocą czynnika Sox2 oraz Sox2 i c-Myc do komórki iNS |
CA2892045C (en) * | 2012-11-21 | 2022-05-31 | Ptc Therapeutics, Inc. | Substituted reverse pyrimidine bmi-1 inhibitors |
KR20140121317A (ko) * | 2013-04-06 | 2014-10-15 | 서울대학교산학협력단 | 비신경 세포로부터 유도 신경 줄기 세포의 생산 방법 및 이에 의하여 생산되는 유도 신경 줄기 세포 |
MX2016000557A (es) * | 2013-07-23 | 2016-04-20 | Hoffmann La Roche | Conversion basada en moleculas pequeñas de celulas somaticas en celulas de cresta neural. |
CN104342401B (zh) * | 2013-07-25 | 2017-04-05 | 中国科学院广州生物医药与健康研究院 | 利用确定的细胞因子组合促进成纤维细胞转分化为脂肪细胞 |
DK3060237T3 (da) | 2013-10-25 | 2021-10-25 | Univ Wayne State | Modificeret omprogrammeringsprotein til anvendelse i behandling af cancer |
JP6478116B2 (ja) | 2013-12-25 | 2019-03-06 | 東亞合成株式会社 | 多能性幹細胞から内胚葉系細胞への分化誘導方法 |
CN104894060B (zh) * | 2014-03-03 | 2018-11-06 | 中国科学院上海生命科学研究院 | 诱导体细胞转分化为神经干细胞的方法及其应用 |
CN104195108B (zh) * | 2014-07-29 | 2018-02-06 | 深圳市三启生物技术有限公司 | 蛋白激酶抑制剂在从非神经细胞制备神经细胞中的用途 |
AU2016226203A1 (en) * | 2015-03-04 | 2017-10-05 | The University Of North Carolina At Chapel Hill | Methods for making neural stem cells and uses thereof |
WO2016160918A1 (en) | 2015-03-31 | 2016-10-06 | The University Of North Carolina At Chapel Hill | Delivery vehicles for stem cells and uses thereof |
JP6691756B2 (ja) | 2015-09-29 | 2020-05-13 | 東亞合成株式会社 | 合成ペプチドを用いた神経幹細胞の生産方法 |
CN116064540A (zh) * | 2015-11-12 | 2023-05-05 | 豪夫迈·罗氏有限公司 | 用于诱导父本ube3a表达的寡核苷酸 |
CN108884444A (zh) * | 2016-03-31 | 2018-11-23 | 味之素株式会社 | 使神经分化能力增强的神经干细胞用培养基 |
KR102311121B1 (ko) | 2016-04-20 | 2021-10-13 | 교토후고리츠다이가쿠호진 | 배양 상피 시트의 제조 방법 |
EP3807402A4 (en) * | 2018-06-14 | 2022-04-27 | Academia Sinica | METHOD FOR GENERATE INDUCED OLIGODENDROCYTE LINEAGE CELLS AND TREATMENT USING SUCH CELLS |
WO2020038851A1 (en) | 2018-08-21 | 2020-02-27 | F. Hoffmann-La Roche Ag | Methods for assessing transendothelial barrier integrity |
US20230340405A1 (en) * | 2020-06-09 | 2023-10-26 | Unist (Ulsan National Institute Of Science And Technology) | Composition for Inducing Direct Cross Differentiation of Somatic Cell into Motor Neuron, and Method for Using Same |
WO2022072325A1 (en) * | 2020-09-29 | 2022-04-07 | NeuExcell Therapeutics Inc. | Neurod1 combination vector |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968829A (en) * | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
CZ2004696A3 (cs) * | 2001-11-09 | 2005-02-16 | Artecel Sciences, Inc. | Endokrinní pankreatická diferenciace buněk stromatu odvozených z adipózní tkáně a její použití |
JP4439396B2 (ja) * | 2002-06-24 | 2010-03-24 | 田辺三菱製薬株式会社 | 神経系細胞の製造方法 |
US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
DE602005014354D1 (de) * | 2004-03-30 | 2009-06-18 | Nsgene As | Therapeutische verwendung des wachstumsfaktors nsg33 |
GB0410011D0 (en) * | 2004-05-05 | 2004-06-09 | Novartis Forschungsstiftung | Neural cell differentiation method |
US8278104B2 (en) * | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
US20100021437A1 (en) * | 2008-04-07 | 2010-01-28 | The McLean Hospital Corporation Whitehead Institute for Biomedical Research | Neural stem cells derived from induced pluripotent stem cells |
JP2011521639A (ja) | 2008-08-12 | 2011-07-28 | インダストリー‐アカデミック・コオペレイション・ファウンデイション,ヨンセイ・ユニバーシティ | ヒト神経幹細胞及びこれを利用した中枢または末梢神経系疾患及び損傷治療用薬学的組成物 |
GB0902034D0 (en) * | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
WO2012022725A2 (en) | 2010-08-19 | 2012-02-23 | F. Hoffmann-La Roche Ag | Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs) |
-
2011
- 2011-08-16 WO PCT/EP2011/064051 patent/WO2012022725A2/en active Application Filing
- 2011-08-16 CA CA2807226A patent/CA2807226A1/en not_active Abandoned
- 2011-08-16 KR KR1020137003961A patent/KR101788903B1/ko active IP Right Grant
- 2011-08-16 BR BR112013003031A patent/BR112013003031A2/pt active Search and Examination
- 2011-08-16 CN CN201180040130.2A patent/CN103068974B/zh not_active Expired - Fee Related
- 2011-08-16 MX MX2013001587A patent/MX348419B/es active IP Right Grant
- 2011-08-16 KR KR1020167007305A patent/KR20160033798A/ko not_active Application Discontinuation
- 2011-08-16 EP EP11743246.8A patent/EP2606126B1/en not_active Not-in-force
- 2011-08-16 JP JP2013524439A patent/JP5905006B2/ja active Active
- 2011-08-16 RU RU2013110127/10A patent/RU2562111C2/ru not_active IP Right Cessation
- 2011-08-16 ES ES11743246.8T patent/ES2580837T3/es active Active
-
2013
- 2013-02-18 US US13/769,762 patent/US9297025B2/en not_active Expired - Fee Related
- 2013-10-22 HK HK13111852.9A patent/HK1184492A1/zh not_active IP Right Cessation
-
2016
- 2016-02-18 US US15/046,885 patent/US20160369234A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2013110127A (ru) | 2014-09-27 |
HK1184492A1 (zh) | 2014-01-24 |
MX2013001587A (es) | 2013-03-21 |
WO2012022725A2 (en) | 2012-02-23 |
EP2606126B1 (en) | 2016-05-18 |
WO2012022725A3 (en) | 2012-04-12 |
US9297025B2 (en) | 2016-03-29 |
JP2013535973A (ja) | 2013-09-19 |
RU2562111C2 (ru) | 2015-09-10 |
ES2580837T3 (es) | 2016-08-29 |
CN103068974B (zh) | 2016-05-11 |
KR101788903B1 (ko) | 2017-10-23 |
MX348419B (es) | 2017-06-12 |
JP5905006B2 (ja) | 2016-04-20 |
US20160369234A1 (en) | 2016-12-22 |
CN103068974A (zh) | 2013-04-24 |
EP2606126A2 (en) | 2013-06-26 |
KR20160033798A (ko) | 2016-03-28 |
KR20130030303A (ko) | 2013-03-26 |
CA2807226A1 (en) | 2012-02-23 |
US20140051171A1 (en) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013003031A2 (pt) | método de produção de células hastes neurais (chn), células hastes neurais e seu uso, composição terapêutica e banco biológico de nscs | |
TR201911199T4 (tr) | Hücre büyümesini arttırmak için tedavi. | |
MX2013007379A (es) | Mutantes tipo papel lija de bacillus y metodos de uso de los mismos para mejorar el crecimiento vegetal, promover la salud de plantas y controlar enfermedades y plagas. | |
WO2016162747A3 (en) | Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases | |
BR112016007853A2 (pt) | método de produção de célula epitelial de pigmento retinal | |
NZ602497A (en) | Enterobacter sp. 638 and methods of use thereof | |
WO2013177133A3 (en) | Generation of human ips cells by a synthetic self- replicative rna | |
MX2016005585A (es) | Exopolisacarido para el tratamiento y/o el cuidado de la piel, medios de cultivo y composiciones del mismo. | |
SG176656A1 (en) | Microorganisms for the production of 1,4-butanediol and related methods | |
BR112012028049A2 (pt) | organismo microbiano de ocorrência não natural e método para produzir butadieno, meio de cultura, butadieno biossintetizado, composição, produto químico orgânico, polímero e uso de butadieno biossintetizado | |
SG196784A1 (en) | Stem cell cultures | |
IL225923B (en) | Cell culture material derived from a plant, methods for its preparation and uses thereof | |
MX2011009369A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2011010908A (es) | Anticuerpos anti-tnf-alfa y sus usos. | |
BRPI0919804A8 (pt) | Métodos e composição para o tratamento de problemas dermatológicos e/ou condições de cabelo | |
AU323704S (en) | Medical instrument | |
MY189592A (en) | Method for producing cerebellar progenitor tissue | |
UA105405C2 (ru) | Гуманизированное антитело против человеческого il-22ra | |
MX2011008825A (es) | 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3. | |
BR112015032235A2 (pt) | método de produção de células da crista neural, células da crista neural, células de schwann, condrócitos, células musculares lisas ou adipócitos, biobanco de células da crista neural, uso das células, composição terapêutica e métodos e usos | |
BR112012022238A2 (pt) | pele artificial | |
MX2011009338A (es) | 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3. | |
WO2010022194A3 (en) | Compositions and methods for generation of pluripotent stem cells | |
FI20115328A (fi) | Uusia kutinaaseja, niiden tuottaminen ja käytöt | |
CL2012003626A1 (es) | Uso de acido cicorico y una bacteria acido lactica para regular la pigmentacion de la piel; metodo de tratamiento estetico; kit para prevenir transtornos de pigmentacion de la piel y/o imperfecciones de la piel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2529 DE 25-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B07E | Notice of approval relating to section 229 industrial property law |